368.60
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Krystal Biotech focuses on gene-based dermatology treatments as investors watch long-term growth - AD HOC NEWS
KRYSKrystal Biotech Inc Options - Finviz
Price to book forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Krystal Biotech stock soars 16% in three months: Here's why - MSN
Krystal Biotech (KRYS) soars 3.4%: Is further upside left in the stock? - MSN
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Krystal Biotech, Inc. Actuals & Estimates (FWB:4KB) - TradingView
Form 4 Krystal Biotech Inc For: 26 June By Investing.com - Investing.com South Africa
Krystal Biotech, Inc. Actuals & Estimates (MIL:1KRYS) - TradingView
Responsive Playbooks and the KRYS Inflection - Stock Traders Daily
Krystal Biotech EVP sells $347,270 in common stock - Investing.com UK
Krystal Biotech EVP sells $347,270 in common stock By Investing.com - Investing.com South Africa
Krystal Biotech (KRYS) EVP executes 10b5-1 option exercise and 1,000-share sale - Stock Titan
Krystal Biotech Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
High Growth Tech Stocks In US For June 2026 - simplywall.st
Krystal Biotech stock hits all-time high at 357.65 USD By Investing.com - Investing.com Australia
Krystal Biotech, Inc. Actuals & Estimates (MUN:4KB) - TradingView
Form 144 Krystal Biotech For: 25 June By Investing.com - Investing.com Australia
Krystal Biotech stock hits all-time high at 357.65 USD - Investing.com
KRYS (KRYS) option exercise: 1,000 shares to be sold on 06/25/2026 - Stock Titan
Krystal Biotech earnings outlook and chart levels, shares on Nasdaq watched by biotech investors - Ad-hoc-news.de
Price to book forward of Krystal Biotech, Inc. – SWB:4KB - TradingView
KRYS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Enterprise value to revenue forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Price to sales forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Price to earnings forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
The Brown Capital Management Small Company Fund Bets on Krystal Biotech (KRYS) for Its Resilient Revenue Stream - Insider Monkey
Krystal Biotech updates key Vyjuvek filing, shares trade firmly on Nasdaq - Ad-hoc-news.de
Krystal Biotech (KRYS) Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels - Sahm
Krystal Biotech, Inc. (KRYS) Stock Analysis: A $10.26 Billion Market Cap Player in Gene Therapy with Strong Buy Ratings - DirectorsTalk Interviews
3 Biotech Firms With Major Potential Catalysts in the Coming Months - MarketBeat
3 US Pharmaceutical Stocks With Strong Margins And Earnings Growth - Sahm
TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $403 - Moomoo
KRYS Maintained by TD Cowen -- Price Target Raised to $403 - GuruFocus
Krystal Biotech stock hits all-time high at 332.33 USD By Investing.com - Investing.com Nigeria
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead - Yahoo Finance
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead - The Motley Fool
Krystal Biotech Inc (KRYS) Institutional Confidence - TradingKey
Krystal Biotech Inc (KRYS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Krystal Biotech Inc (KRYS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):